摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S)-2-(2-(tert-butoxycarbonylamino)-4-(methylthio)butanamido)-4-methylpentanoic acid | 33014-87-8

中文名称
——
中文别名
——
英文名称
(2S)-2-(2-(tert-butoxycarbonylamino)-4-(methylthio)butanamido)-4-methylpentanoic acid
英文别名
Boc-L-Met-L-Leu-OH;Boc-Met-Leu-OH;Boc-Met-Leu;(2S)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-methylsulfanylbutanoyl]amino]pentanoic acid
(2S)-2-(2-(tert-butoxycarbonylamino)-4-(methylthio)butanamido)-4-methylpentanoic acid化学式
CAS
33014-87-8
化学式
C16H30N2O5S
mdl
——
分子量
362.491
InChiKey
XMZUESJXUFGXQI-RYUDHWBXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    127-129 °C
  • 沸点:
    577.7±50.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    24
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    130
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

点击查看最新优质反应信息

文献信息

  • Phase-transfer reagents as C-terminal protecting groups; facile incorporation of free amino acids or peptides into peptide sequences
    作者:Shui-Tein Chen、Kung-Tsung Wang
    DOI:10.1039/c39900001045
    日期:——
    Phase-transfer reagents (basic, neutral, and acidic) can effect temporary protection of carboxy groups by salt formation in C-terminal free amino acids or peptides during peptide synthesis; the use of acidic or neutral phase-transfer reagents as the C-terminal protecting group will not affect the nucleophilicity of the amino group of the salts thus prepared in an organic solvent.
    相转移试剂(碱性,中性和酸性)可通过在肽合成过程中在C端游离氨基酸或肽中形成盐来暂时保护羧基。使用酸性或中性相转移试剂作为C-末端保护基不会影响在有机溶剂中如此制得的盐的基的亲核性。
  • Synthesis and Biological Evaluation of Curcumin Derivatives with Water-Soluble Groups as Potential Antitumor Agents: An in Vitro Investigation Using Tumor Cell Lines
    作者:Luyang Ding、Shuli Ma、Hongxiang Lou、Longru Sun、Mei Ji
    DOI:10.3390/molecules201219772
    日期:——
    Three series of curcumin derivatives including phosphorylated, etherified, and esterified products of curcumin were synthesized, and their anti-tumor activities were assessed against human breast cancer MCF-7, hepatocellular carcinoma Hep-G2, and human cervical carcinoma HeLa cells. Compared with curcumin, compounds 3, 8, and 9 exhibited stronger antitumor cell line growth activities against HeLa cells. Compound 12 also showed higher antitumor cell line growth activities on MCF-7 cells than curcumin. Among them, 4-((1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl)-2-methoxyphenyl dihydrogen phosphate(3) showed the strongest activity with an half maximal inhibitory concentration (IC50) of 6.78 µM against HeLa cells compared with curcumin with an IC50 of 17.67 µM. Stabilities of representatives of the three series were tested in rabbit plasma in vitro, and compounds 3 and 4 slowly released curcumin in plasma. The effect of compound 3 on HeLa cell apoptosis was determined by examining morphological changes by DAPI (4′,6-diamidino-2-phenylindole) staining as well as Annexin V-FITC/ Propidium Iodide (PI) double staining and flow cytometry. The results showed that 3 induced cellular apoptosis in a dose-dependent manner. Together our findings show that 3 merits further investigation as a new potential antitumor drug candidate.
    合成了三类姜黄素生物,包括磷酸化、醚化和酯化的姜黄素产品,并评估了它们对人乳腺癌MCF-7、肝细胞癌Hep-G2和人宫颈癌HeLa细胞的抗肿瘤活性。与姜黄素相比,化合物3、8和9在对HeLa细胞的抗肿瘤细胞生长活性方面表现出更强的活性。化合物12在MCF-7细胞上的抗肿瘤细胞生长活性也高于姜黄素。其中,化合物4-((1E,6E)-7-(4-羟基-3-甲氧基苯基)-3,5-二氧杂庚-1,6-二烯基)-2-甲氧基苯基二氢磷酸(3)表现出最强的活性,对HeLa细胞的半最大抑制浓度(IC50)为6.78 µM,而姜黄素的IC50为17.67 µM。在体外测试了这三类代表化合物在兔血浆中的稳定性,化合物3和4在血浆中缓慢释放姜黄素。通过DAPI(4′,6-二基-2-苯基吲哚)染色以及Annexin V-FITC/化丙锭(PI)双重染色和流式细胞术,确定了化合物3对HeLa细胞凋亡的影响。结果显示,化合物3以剂量依赖的方式诱导细胞凋亡。综上所述,我们的研究结果表明,化合物3值得进一步研究作为新的潜在抗肿瘤药物候选者。
  • New fMLF-OMe Analogues Containing Constrained Mimics of Phenylalanine Residue
    作者:Ines Torrini、Gaia Mastropietro、Giampiero Pagani Zecchini、Mario Paglialunga Paradisi、Gino Lucente、Susanna Spisani
    DOI:10.1002/(sici)1521-4184(199805)331:5<170::aid-ardp170>3.0.co;2-b
    日期:1998.5
    different analogues of the native ligand have been synthesized and evaluated. Compounds 1‐3 possess the general formula HCO‐Met‐Leu‐Xaa‐OMe with Xaa = N‐benzylglycine, N‐benzylphenylalanine, and α,α‐dibenzylglycine, respectively. In the analogue 4 the constraint at the C‐terminus has been obtained by incorporating a 2‐oxopiperazine ring, made up of two phenylalanine residues, to replace the native
    在一项旨在阐明 HCO-Met-Leu-Phe-OMe (fMLF-OMe) 结构特征的研究项目中,该结构特征控制与 C-末端残基对应的受体的相互作用,天然配体的四种不同类似物具有被合成和评估。化合物 1-3 的通式为 HCO-Met-Leu-Xaa-OMe,其中 Xaa = N-苄基甘氨酸、N-苄基苯丙酸和 α, α-二苄基甘酸。在类似物 4 中,通过引入由两个苯丙酸残基组成的 2-氧代哌嗪环来取代天然的 C-末端 Phe 残基,从而获得了 C-末端的约束。讨论了化学修饰对新类似物活性的影响。
  • Selective C−H Acyloxylation of Sulfides/Disulfides Enabled by Hypervalent Iodine Reagents
    作者:Shuang Wu、Yiyun Chen
    DOI:10.1002/adsc.202300360
    日期:2023.8.15
    Herein, we report the α−C−H acyloxylation of sulfides and disulfides enabled by hypervalent iodine(III) reagents via photoredox catalysis. The methoxylbenziodoxole derivatives serve as the hydrogen atom transfer agent, the mild oxidant, and the acyloxylation source in the reaction. External nucleophiles can also be introduced to the α−C−H of sulfides. The reaction applies to various aryl and alkyl
    在此,我们报道了高价 (III) 试剂通过光氧化还原催化实现硫化物和二硫化物的 α−C−H 酰氧基化。甲氧基苯并杂环戊烯生物在反应中充当氢原子转移剂、温和氧化剂和酰氧基化源。外部亲核试剂也可以引入到硫化物的 α−C−H 中。该反应适用于各种芳基醚和烷基醚,包括蛋酸肽衍生物。二硫化物首次应用,具有优异的化学选择性和官能团相容性。
  • β-Peptido sulfonamides: for-Met-Leu-Phe-OMe analogues containing taurine and chiral β-amino-ethanesulfonic acid residues
    作者:Cesare Giordano、Marianna Nalli、Mario Paglialunga Paradisi、Anna Sansone、Gino Lucente、Susanna Spisani
    DOI:10.1016/j.farmac.2004.07.014
    日期:2004.12
    A series of new beta-peptido sulfonamides, related to the chemotactic tripeptide fMLF-OMe, has been synthesized. The examined 1a,b-7a,b models contain the achiral -HN-(CH(2))(2)-SO(2)- taurine (Tau) residue or the chiral -HN-CH(nBu)-CH(2)-SO(2)- and -HN-CH(iBu)-CH(2)-SO(2)- residues, corresponding to the beta-aminocarboxylic acid counterparts beta(3)-HNle and beta(3)-HLeu, respectively. The biological activity of the new analogues has been determined on human neutrophils and compared with that of the reference ligand as well as that of the previously studied related models. The results are analyzed in terms of structure-activity relationships. The conformational preferences of the new tripeptides 1b and 2b, containing a central chiral beta-amino-ethanesulfonic acid residue, have also been discussed.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸